A regulatory non-interventional study to monitor the safety and efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean patients with Chronic Kidney Disease (CKD)

Study protocol

Initial protocol

[Eng]1245-0323-onis-protocol-final-v2-EUPAS.pdf

English (654.31 KB - PDF) View document

Updated protocol

Protocol and Protocol Amendment_02 Mar 2026_v3.pdf

First published: 23/04/2026

English (1.06 MB - PDF) View document

Protocol and Protocol Amendment_02 Mar 2026_v3.pdf

First published: 23/04/2026

English (1.06 MB - PDF) View document

1245-0323-protocol-v3-final_Redacted.pdf

First published: 04/02/2025

English (1021.66 KB - PDF) View document

Study results

Study report

Abstract of study report

1245-0323_Synopsis.pdf

English (443.63 KB - PDF) View document

Other information

Secondary tabs